Further, the abnormally high IDO1 expression in cancer cells, associated with tryptophan metabolic reprogramming, could contribute to L-kyn changes in EVs, resulting in increased L-kyn levels in EVs obtained from plasma and the TME in OC patients. Here, IDO1 is linked to cancer.